Ampio begins Phase 1 clinical trial of inhaled Ampion for COVID-19

Ampio begins Phase 1 clinical trial of inhaled Ampion for COVID-19

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it hasbegun recruiting and enrolling patients in a Phase Imulti-center, randomized, controlled trial for a total of 40... Read More

Thursday October 29, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, Michael Macaluso

RVC: Investments in “PandemicTech” companies on the rise

RVC: Investments in “PandemicTech” companies on the rise

DENVER -- Rockies Venture Club made three investments in promising Colorado startups in September, two of which are "PandemicTech" companies representing a trend towards startups innovating in... Read More

Thursday October 22, 2020 0 comments Tags: Denver, Rockies Venture Club, Peter Adams, COVID-19

Reven Pharmaceuticals wins FDA nod of IND application for COVID treatment with Rejuveinix

Reven Pharmaceuticals wins FDA nod of IND application for COVID treatment with Rejuveinix

GOLDEN -- Reven today announced the U.S. Food and Drug Administration has approved its Investigational New Drug application in connection with its lead anti-inflammatory/anti-oxidant... Read More

Thursday October 22, 2020 0 comments Tags: Golden, Reven Pharmaceuticals, Reven Holdings, Rejuveinix, COVID-19, Fatih Uckun, Michael Volk, Peter Lange

Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer

Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer

AURORA -- Summit Biolabs, Inc. , an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head neck cancer, and the Colorado Center for Personalized... Read More

Thursday October 15, 2020 0 comments Tags: Aurora, Summit Biolabs, COVID-19, Colorado Center for Personalized Medicine, Kathleen Barnes, Bob Blomquist

Radish's ChoiceView provides Voice-to-Visual Navigation on Mile High United Way 2-1-1 Help Center mobile calls

Radish's ChoiceView provides Voice-to-Visual Navigation on Mile High United Way 2-1-1 Help Center mobile calls

BOULDER -- Radish Systems announced deployment of its ChoiceView Visual Phonebot at Mile High United Way's 2-1-1 Help Center. ChoiceView allows callers with mobile devices to visually navigate... Read More

Friday October 2, 2020 0 comments Tags: Boulder, Radish Systems, ChoiceView Visual Phonebot, COVID-19

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

GOLDEN -- Reven Holdings, Inc. today announced it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19... Read More

Wednesday September 30, 2020 0 comments Tags: Golden, Reven Holdings, Reven Pharmaceuticals, DSG, Fatih Uckun, Michael Volk, Tony Varano, COVID-19

CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

FORT COLLINS -- A team of scientists at Colorado State University was awarded a base contract worth $3.1 million from the National Institutes of Health to continue development... Read More

Tuesday September 22, 2020 0 comments Tags: Fort Collins, CSU, COVID-19, NIH, SolaVAX, Ray Goodrich, CSU Infectious Disease Research Center , CSU BioMARC

FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients

FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients

ENGLEWOOD-- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it has received an Investigational New Drug designation from the U.S. Food and Drug Administration, allowing the company to... Read More

Monday September 21, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, FDA